Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety of Oral Propranolol for Infantile Hemangioma.
Droitcourt C, Kerbrat S, Rault C, Botrel MA, Happe A, Garlantezec R, Guillot B, Schleich JM, Oger E, Dupuy A. Droitcourt C, et al. Among authors: kerbrat s. Pediatrics. 2018 Jun;141(6):e20173783. doi: 10.1542/peds.2017-3783. Pediatrics. 2018. PMID: 29844139
Isotretinoin and risk factors for suicide attempt: a population-based comprehensive case series and nested case-control study using 2010-2014 French Health Insurance Data.
Droitcourt C, Poizeau F, Kerbrat S, Balusson F, Drezen E, Happe A, Travers D, Oger E, Dupuy A. Droitcourt C, et al. Among authors: kerbrat s. J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1293-1301. doi: 10.1111/jdv.16005. Epub 2019 Nov 20. J Eur Acad Dermatol Venereol. 2020. PMID: 31587374 Free article.
Association Between Early Severe Cardiovascular Events and the Initiation of Treatment With the Anti-Interleukin 12/23p40 Antibody Ustekinumab.
Poizeau F, Nowak E, Kerbrat S, Le Nautout B, Droitcourt C, Drici MD, Sbidian E, Guillot B, Bachelez H, Ait-Oufella H, Happe A, Oger E, Dupuy A. Poizeau F, et al. Among authors: kerbrat s. JAMA Dermatol. 2020 Nov 1;156(11):1208-1215. doi: 10.1001/jamadermatol.2020.2977. JAMA Dermatol. 2020. PMID: 32902568 Free PMC article.
Overall Survival Among Chemotherapy-Naive Patients With Castration-Resistant Prostate Cancer Under Abiraterone Versus Enzalutamide: A Direct Comparison Based on a 2014-2018 French Population Study (the SPEAR Cohort).
Scailteux LM, Campillo-Gimenez B, Kerbrat S, Despas F, Mathieu R, Vincendeau S, Balusson F, Happe A, Nowak E, Oger E. Scailteux LM, et al. Among authors: kerbrat s. Am J Epidemiol. 2021 Feb 1;190(3):413-422. doi: 10.1093/aje/kwaa190. Am J Epidemiol. 2021. PMID: 32944756 Free article.
Patients with Metastatic Melanoma Receiving Anticancer Drugs: Changes in Overall Survival, 2010-2017.
Poizeau F, Kerbrat S, Happe A, Rault C, Drezen E, Balusson F, Tuppin P, Guillot B, Thuret A, Boussemart L, Dinulescu M, Pracht M, Lesimple T, Droitcourt C, Oger E, Dupuy A. Poizeau F, et al. Among authors: kerbrat s. J Invest Dermatol. 2021 Apr;141(4):830-839.e3. doi: 10.1016/j.jid.2020.07.038. Epub 2020 Oct 10. J Invest Dermatol. 2021. PMID: 33049268 Free article.
Hospitalization for adverse events under abiraterone or enzalutamide exposure in real-world setting: A French population-based study on prostate cancer patients.
Scailteux LM, Despas F, Balusson F, Campillo-Gimenez B, Mathieu R, Vincendeau S, Happe A, Nowak E, Kerbrat S, Oger E. Scailteux LM, et al. Among authors: kerbrat s. Br J Clin Pharmacol. 2022 Jan;88(1):336-346. doi: 10.1111/bcp.14972. Epub 2021 Jul 22. Br J Clin Pharmacol. 2022. PMID: 34224605 Free article.
27 results